NDC product
INJECTION · Fresenius Kabi Austria GmbH
NDC 18124-016 · Fresenius Kabi Austria GmbH
Key facts
| Product NDC | 18124-016 |
|---|---|
| Nonproprietary name | hydroxyprogesterone caproate |
| Substances | HYDROXYPROGESTERONE CAPROATE |
| Dosage form | INJECTION |
| Labeler | Fresenius Kabi Austria GmbH |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Feb 3, 2011 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: